title: Reply to M. Roschewski et al.
authors.affiliation: St James's University Hospital, Leeds, United Kingdom.
authors.forename: Andy C
authors.initials: AC
authors.lastname: Rawstron
authors.forename: J Anthony
authors.initials: JA
authors.lastname: Child
authors.forename: Ruth M
authors.initials: RM
authors.lastname: de Tute
authors.forename: Faith E
authors.initials: FE
authors.lastname: Davies
authors.forename: Walter M
authors.initials: WM
authors.lastname: Gregory
authors.forename: Sue E
authors.initials: SE
authors.lastname: Bell
authors.forename: Alexander J
authors.initials: AJ
authors.lastname: Szubert
authors.forename: Nuria
authors.initials: N
authors.lastname: Navarro Coy
authors.forename: Mark T
authors.initials: MT
authors.lastname: Drayson
authors.forename: Sylvia
authors.initials: S
authors.lastname: Feyler
authors.forename: Fiona M
authors.initials: FM
authors.lastname: Ross
authors.forename: Gordon
authors.initials: G
authors.lastname: Cook
authors.forename: Graham H
authors.initials: GH
authors.lastname: Jackson
authors.forename: Gareth J
authors.initials: GJ
authors.lastname: Morgan
authors.forename: Roger G
authors.initials: RG
authors.lastname: Owen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D018365:Neoplasm, Residual / Q000188:drug therapy* / Q000473:pathology*